Skip to search boxSkip to navigationSkip to main content

Quantitative Fit Testing on Filtering Facepiece Respirators in Use by Peruvian Healthcare Workers Caring for Tuberculosis Patients during the COVID-19 Pandemic: PROFIT Study 2020

*Corresponding author for this work
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

6618

Journal (Volume, Issue Number)

International Journal of Environmental Research and Public Health (Volume 20, Issue 16)

Publication milestones

  • Published - 08/2023

Publication status

Published - 08/2023

ISSN

1661-7827

Publication IDs

  • Scopus: 85168741380
  • PubMed: 37623201

Abstract

Background: The COVID-19 pandemic has promoted a shortage of filtering facepiece respirators (FFRs) and the emergence of new FFRs brands. We aimed to determine the fit provided by in-use FFRs in Peruvian healthcare workers (HCWs) during the COVID-19 pandemic. Methods: We enrolled 279 HCWs from 37 primary healthcare centers with highest burden of care for TB in Peru, of which 263 were assessed using quantitative fit tests (QNFT). Results were expressed as real-time fit factor (rt-FF) and overall fit factor (overall-FF), which was categorized as ≥100 (optimal result), 50–99, and <50. Results: We identified 3M 1860 FFRs (33.1%), Xiantao Zhong Yi ZYB-11 FFRs (24.6%) and Makrite 9500 FFRs (20.5%), mainly. Eighty-seven FFRs (33.1%) had an optimal overall-FF, 27 (10.3%) between 50–99, and 149 (56.6%) less than 50. Of the 87 FFRs with optimal overall-FF, 73 (83.9%) were 3M 1860 FFRs. Of the 27 FFRs with overall-FF between 50–99, 7 (25.9%) were Makrite 9500, while of the 149 with overall-FF less than 50, 58 (38.9%), and 47 (31.5%) were Xiantao Zhong Yi ZYB-11 and Makrite 9500, respectively. Conclusion: Xiantao Zhong Yi and Makrite FFRs do not adapt adequately to the face of Peruvian HCWs, most having fit factors less than 50.

Funding Details

The PROFIT study 2020 was funded by the National Institute of Health - Peru (CENSOPAS-unit cost N°5005157) corresponding to infection control and biosafety measures in tuberculosis care services. The PROFIT 2020 is part of an occupational surveillance program for respiratory protection focused on HCWs developed within the framework of the National Center for Occupational Health and Environmental Health (CENSOPAS in Spanish). The APC was funded by Universidad Privada San Juan Bautista (073-2023-CU-UPSJB).
FundersFunding numbers
Universidad Privada San Juan Bautista
073-2023-CU-UPSJB
NIH
5005157

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
2
Citations
1
Mentions
1

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well